Sales rise 15.10% to Rs 853.31 crore
Net profit of Alembic Pharmaceuticals rose 0.81% to Rs 93.79 crore in the quarter ended March 2018 as against Rs 93.04 crore during the previous quarter ended March 2017. Sales rose 15.10% to Rs 853.31 crore in the quarter ended March 2018 as against Rs 741.35 crore during the previous quarter ended March 2017.For the full year,net profit rose 2.35% to Rs 412.63 crore in the year ended March 2018 as against Rs 403.16 crore during the previous year ended March 2017. Sales declined 0.12% to Rs 3130.81 crore in the year ended March 2018 as against Rs 3134.61 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales853.31741.35 15 3130.813134.61 0 OPM %20.3018.23 -20.5419.63 - PBDT172.53133.66 29 646.73612.06 6 PBT140.96111.82 26 541.27529.09 2 NP93.7993.04 1 412.63403.16 2
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
